tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market

Ascentage Pharma Group International (6855) Income Statement

Compare
4 Followers

Ascentage Pharma Group International Income Statement

Last quarter (Q2 2025), Ascentage Pharma Group International's total revenue was ¥233.70M, an increase of 63.77% from the same quarter last year. In Q2, Ascentage Pharma Group International's net income was ¥-590.77M. See Ascentage Pharma Group International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M¥ 12.45M
Gross Profit
¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M¥ 10.48M
Operating Expenses
¥ 1.33B¥ 1.08B¥ 1.07B¥ 957.75M¥ 694.91M
Depreciation and Amortization
¥ 79.17M¥ 93.19M¥ 47.42M¥ 17.18M¥ 27.42M
EBITDA
¥ -299.63M¥ -743.61M¥ -835.99M¥ -915.99M¥ -641.77M
Operating Income
¥ -378.80M¥ -891.99M¥ -883.41M¥ -933.17M¥ -684.43M
Other Income/Expenses
¥ -16.45M¥ -40.87M¥ -3.77M¥ 100.92M¥ 8.98M
Pretax Income
¥ -395.25M¥ -932.86M¥ -887.17M¥ -832.25M¥ -675.45M
Net Income
¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M¥ -677.61M
Per Share Metrics
Basic EPS
¥ -1.34¥ -3.28¥ -3.35¥ -3.07¥ -3.14
Diluted EPS
¥ -1.34¥ -3.28¥ -3.35¥ -3.07¥ -3.14
Weighted Average Shares Outstanding
302.06M 282.30M 263.67M 254.62M 215.91M
Weighted Average Shares Outstanding (Diluted)
302.06M 282.30M 263.67M 254.62M 215.91M
Currency in CNY

Ascentage Pharma Group International Earnings and Revenue History